Home/Pipeline/TaurusNXT TAVR System

TaurusNXT TAVR System

Aortic Stenosis/Regurgitation

Pre-market (NMPA under review)Clinical enrollment completed

Key Facts

Indication
Aortic Stenosis/Regurgitation
Phase
Pre-market (NMPA under review)
Status
Clinical enrollment completed
Company

About Peijia Medical

A leading Chinese medtech company developing innovative transcatheter heart valve and neurointerventional devices for structural heart disease and stroke.

View full company profile

Therapeutic Areas